A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma
Clinical trial NCT03136653 · COMPLETED
Trial details
- NCT number
- NCT03136653
- Sponsor
- Molecular Partners AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-23
- Primary completion
- 2020-10-12
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.